This systematic review and meta-analysis evaluates the pooled prevalence of Salmonella and its associated antimicrobial resistance (AMR) patterns within global wild bird populations. The study synthesizes data to provide a comprehensive overview of the current burden of infection and resistance in this ecological niche.
The analysis indicates a pooled prevalence of Salmonella spp. at 5.77% (95% CI: 4.21–7.54%). Regional breakdowns reveal higher prevalence in Asia (10.13%) compared to Africa (6.66%) and Europe (6.14%). Specific serovars show distinct distributions, with S. Typhimurium at 4.12% and S. Enteritidis at 1.42%. Prevalence also varied by bird order, with Accipitriformes at 6.85% and Charadriiformes at 6.15%.
Antimicrobial resistance profiles demonstrate significant concerns across multiple drug classes. Resistance to macrolides was observed in 29.6% of isolates, while monobactam resistance reached 22.9%. Penicillin resistance was noted in 14.7% of cases. Temporal trends indicate a statistically significant increase in resistance to fluoroquinolones (R2 = 19.21%, p = 0.003) and a more pronounced increase in resistance to penicillin/β-lactamase inhibitors (R2 = 66.75%, p < 0.01).
The authors interpret these findings as suggesting an escalating environmental selective pressure. Consequently, the review supports the need for integrated One Health surveillance approaches and coordinated global policy interventions to monitor and mitigate the dissemination of resistance across ecosystems. No adverse events or tolerability data were reported, as this was an ecological assessment rather than a clinical trial.
View Original Abstract ↓
BackgroundThe lack of consolidated global data on the prevalence and antimicrobial resistance (AMR) profiles of Salmonella in wild bird populations hinders our understanding of their epidemiological role as reservoirs and disseminators of resistant strains and impedes accurate evaluation of their potential implication for global public health.MethodsA random-effects meta-analysis was conducted to generate a pooled prevalence estimate of Salmonella and its AMR patterns in the global wild bird populations.ResultsThe pooled prevalence of Salmonella spp. in wild birds was 5.77% (95% CI: 4.21–7.54%), with the highest prevalence observed in Asia (10.13%), followed by Africa (6.66%) and Europe (6.14%). Serovar-specific analysis revealed that S. Typhimurium had the highest prevalence (4.12%), followed by S. Enteritidis (1.42%). Significant variation in prevalence across avian taxonomic orders has been detected, with Accipitriformes (6.85%) and Charadriiformes (6.15%) exhibiting the highest infection rates. Resistance to critically important antimicrobials ranged from 0% to 29.6%, with the highest prevalence observed for macrolides (29.6%), monobactams (22.9%), and penicillins (14.7%). In addition, a significant temporal increase in resistance was observed for key antimicrobials, including fluoroquinolones (R2 = 19.21%, p = 0.003) and penicillin/β-lactamase inhibitors (R2 = 66.75%, p < 0.01), suggesting an escalating environmental selective pressure.ConclusionsA significant temporal increase to some critically important antimicrobials highlights the growing influence of environmental selective pressures on AMR dynamics in wild bird populations. These trends suggest increasing environmental exposure to antimicrobial residues and resistant determinants, reinforcing the role of wildlife as sentinels and potential reservoirs for clinically relevant resistance with important implications for ecosystem health and public health surveillance. Given the interconnectedness between wildlife, livestock, and humans, the presence of AMR Salmonella isolates in wild birds represents a potential public health concern, even when resistance levels are low to moderate. These findings support the need for integrated One Health surveillance approaches and coordinated global policy interventions to monitor and mitigate the dissemination of resistance across ecosystems.